El reto de la medición de la gravedad y la letalidad en el curso de la pandemia de COVID-19

Águila Mejía, Javier del; Redondo Bravo, Lidia; Guzmán Herrador, Bernardo R; Suárez Rodríguez, Berta; García San Miguel, Lucía.
Rev. esp. salud pública ; 94: 0-0, 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-196393

Documentos relacionados

  1. Humoral Immune Response to SARS-CoV-2 in Iceland.
  2. Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020.
  3. Seroprevalence against Toscana virus in Spain: The case of the autonomous community of Madrid.
  4. Tasas de letalidad por SARS-CoV-2 según Comunidades Autónomas durante la segunda onda epidémica en España
  5. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
  6. COVID-19: test, trace and isolate-new epidemiological data.
  7. First serological study of Dirofilaria immitis antibodies in household domestic ferrets (Mustela putorius furo) in southern Spain - Short communication.
  8. Hotspot of Crimean-Congo Hemorrhagic Fever Virus Seropositivity in Wildlife, Northeastern Spain.
  9. Hepatitis C virus: Testing rate and attrition at linkage to specialized care, Catalonia, Spain 2011-2016.
  10. The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries : A Nine-Country Demographic Study.